Skip to content
Disclosery

MARSHALL WACE, LLP: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on BIO, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 18,980 BIO shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 18,980 shares
    Change vs previous 13F -14,237 shares

    <0.01% of the 13F portfolio, value $5,572,716.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 33,217 shares
    Change vs previous 13F +21,657 shares

    0.01% of the 13F portfolio, value $9,259,238.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 11,560 shares
    Change vs previous 13F -1,054 shares

    <0.01% of the 13F portfolio, value $3,502,565.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 12,614 shares
    Change vs previous 13F +11,688 shares

    <0.01% of the 13F portfolio, value $3,536,840.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 926 shares
    Change vs previous 13F -26,169 shares

    <0.01% of the 13F portfolio, value $223,462.

    13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 27,095 shares
    Change vs previous 13F +24,816 shares

    0.01% of the 13F portfolio, value $6,599,257.

    13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,279 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $748,674.

    13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).